Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are used for relieving pain and inflammation accompanying numerous disease states. The primary therapeutic mechanism of these widely used drugs is the inhibition of cyclooxygenase 1 and 2 (COX1, 2) enzymes that catalyze the conversion of arachidonic acid into prostaglandins. At higher doses, NSAIDs are used for prevention of certain types of cancer and as experimental treatments for Alzheimer’s disease. In the immune system, various NSAIDs have been reported to influence neutrophil function and lymphocyte proliferation, and affect ion channels and cellular calcium homeostasis. Transient receptor potential melastatin 7 (TRPM7) cation channels are highly expressed in T lymphocytes and are inhibited by Mg2+, acidic pH, and polyamines. Here, we report a novel effect of naproxen, ibuprofen, salicylate, and acetylsalicylate on TRPM7. At concentrations of 3–30mM, they reversibly inhibited TRPM7 channel currents. By measuring intracellular pH with the ratiometric indicator BCECF, we found that at 300μM to 30mM, these NSAIDs reversibly acidified the cytoplasm in a concentration-dependent manner, and propose that TRPM7 channel inhibition is a consequence of cytosolic acidification, rather than direct. NSAID inhibition of TRPM7 channels was slow, voltage-independent, and displayed use-dependence, increasing in potency upon repeated drug applications. The extent of channel inhibition by salicylate strongly depended on cellular PI(4,5)P2 levels, as revealed when this phospholipid was depleted with voltage-sensitive lipid phosphatase (VSP). Salicylate inhibited heterologously expressed wildtype TRPM7 channels but not the S1107R variant, which is insensitive to cytosolic pH, Mg2+, and PI(4,5)P2 depletion. NSAID-induced acidification was also observed in Schneider 2 cells from Drosophila, an organism that lacks orthologous COX genes, suggesting that this effect is unrelated to COX enzyme activity. A 24-h exposure to 300μM–10mM naproxen resulted in a concentration-dependent reduction in cell viability. In addition to TRPM7, the described NSAID effect would be expected to apply to other ion channels and transporters sensitive to intracellular pH.

Highlights

  • Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used as medication for mild and moderate pain in diseases such as rheumatoid arthritis, spondyloarthropathies and gout (Rider and Jordan, 2010; Firth, 2012)

  • The present study was undertaken to characterize the effects of several common NSAIDs ibuprofen, naproxen, salicylate, and acetylsalicylate on Transient receptor potential melastatin 7 (TRPM7) channels

  • Since TRPM7 channels are inhibited by acidic pH (Chokshi et al, 2012b), cytosolic acidification is likely responsible for NSAID-mediated inhibition of these channels

Read more

Summary

Introduction

Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used as medication for mild and moderate pain in diseases such as rheumatoid arthritis, spondyloarthropathies and gout (Rider and Jordan, 2010; Firth, 2012). The mechanism of their analgesic action is the inhibition of cyclooxygenase enzymes COX1 and COX2, which catalyze the production of prostaglandins responsible for the pain and inflammation symptoms (Vane, 1971; Fitzpatrick, 2004; Burke et al, 2006). High doses of aspirin and salicylate (millimolar range) have long been known to cause tinnitus, hearing loss and cochlea degeneration (Wei et al, 2010; Namikawa et al, 2017)

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.